BIOVETA AMOXICILIN 10% Alerta
A product of BIOVETA A.S.
Price and Availability
Composition - 100 g:
-Amoxicillinum (ut trihydricum) 10.00 g
-Lactosum monohydricum 100.00 g
Pharmacological properties:
Amoxicillin is the bactericidal beta-lactamase antibiotics. It inhibits peptidoglycan synthesis in bacteria through mureinsynthetase inhibition and thus eliminates formation of a bacterial wall. Amoxicillin is effective already at very low concentrations against Streptococcus suis type-2 (MIC 90 < 0.02 mg/ml); in addition, it is also effective against other bacteria of Streptococcus, Staphylococcus (penicillinase-negative strains), Corynebacterium, Clostridium, Bacillus, Erysipelothrix, Campylobacter, Pasteurella, Escherichia, Salmonella, Serpulina, Bordetella, and Actinobacillus species.
Amoxicillin is well absorbed from gastrointestinal tract; its therapeutic level in plasma is kept for the whole treatment period. It is eliminated through urine in its active form.
Indication:
Infectious diseases caused by germs sensitive to amoxicillin, e.g. infection of upper airways and lungs, post-delivery infections, urogenital tract infections, hepatobiliary infection, salmonellosis, Coli infections, etc.
Contraindication:
Hypersensitivity to penicillin antibiotics; the preparation shall not be applied to ruminating animals. Never apply the preparation also to rabbits, hamsters, guinea pigs and other small herbivores.
-Amoxicillinum (ut trihydricum) 10.00 g
-Lactosum monohydricum 100.00 g
Pharmacological properties:
Amoxicillin is the bactericidal beta-lactamase antibiotics. It inhibits peptidoglycan synthesis in bacteria through mureinsynthetase inhibition and thus eliminates formation of a bacterial wall. Amoxicillin is effective already at very low concentrations against Streptococcus suis type-2 (MIC 90 < 0.02 mg/ml); in addition, it is also effective against other bacteria of Streptococcus, Staphylococcus (penicillinase-negative strains), Corynebacterium, Clostridium, Bacillus, Erysipelothrix, Campylobacter, Pasteurella, Escherichia, Salmonella, Serpulina, Bordetella, and Actinobacillus species.
Amoxicillin is well absorbed from gastrointestinal tract; its therapeutic level in plasma is kept for the whole treatment period. It is eliminated through urine in its active form.
Indication:
Infectious diseases caused by germs sensitive to amoxicillin, e.g. infection of upper airways and lungs, post-delivery infections, urogenital tract infections, hepatobiliary infection, salmonellosis, Coli infections, etc.
Contraindication:
Hypersensitivity to penicillin antibiotics; the preparation shall not be applied to ruminating animals. Never apply the preparation also to rabbits, hamsters, guinea pigs and other small herbivores.
Product Photos BIOVETA AMOXICILIN 10% of BIOVETA A.S. 1 Photo
Product Videos 1 video
Related categories BIOVETA AMOXICILIN 10% 1 Category
AntibioticsRelated Products 1 Product
Other products of BIOVETA A.S. 1 producto
BIOVETA A.S.
Specialised producer of veterinary immunologicals and pharmaceuticals
The joint-stock company Bioveta with its registered office in Ivanovice na Hané, holder of the Good Manufacturing Practice Certificate (GMP), Good Laboratory Practice Certificate (GLP) and Good Distribution Practice Certificate (GDP) maintains the position of the most significant manufacturer of veterinary, immunobiological and pharmaceutical products in the Czech Republic. The objective of its activities is to offer a wide range of top-quality veterinary products to the professional veterinary and breeder public. Thanks to huge investments made into new production and control premises, effort of its managers and reliability of its employees, Bioveta, a. s. meets the basic standards of European manufacturer of veterinary medicaments, both in the field of correct manufacturing practice, research and development or sales policy.
See company
The joint-stock company Bioveta with its registered office in Ivanovice na Hané, holder of the Good Manufacturing Practice Certificate (GMP), Good Laboratory Practice Certificate (GLP) and Good Distribution Practice Certificate (GDP) maintains the position of the most significant manufacturer of veterinary, immunobiological and pharmaceutical products in the Czech Republic. The objective of its activities is to offer a wide range of top-quality veterinary products to the professional veterinary and breeder public. Thanks to huge investments made into new production and control premises, effort of its managers and reliability of its employees, Bioveta, a. s. meets the basic standards of European manufacturer of veterinary medicaments, both in the field of correct manufacturing practice, research and development or sales policy.
See company
Price and product availability